α-Enolase, also known as ENO1, is an enzyme involved in the glycolytic pathway, converting 2-phosphoglycerate to phosphoenolpyruvate. It also has functions outside of glycolysis, acting as a plasminogen receptor on the cell surface in some tissues. Its expression can be influenced by various factors, including hypoxia, tissue injury, and oncogenesis. α Enolase Activators belong to a class of chemical compounds that influence the activity of α enolase, an enzyme with multifaceted roles in cellular metabolism and physiology. α enolase, also known as phosphopyruvate hydratase, is an essential glycolytic enzyme responsible for catalyzing the conversion of 2-phosphoglycerate (2-PG) to phosphoenolpyruvate (PEP) during glycolysis. This enzymatic reaction is a critical step in glucose metabolism, as it generates high-energy molecules that fuel various cellular processes. Beyond its classical role in glycolysis, α enolase has emerged as a versatile protein involved in additional cellular functions, including acting as a plasminogen receptor on the cell surface, contributing to cell migration, and participating in transcriptional regulation.
α Enolase Activators refer to compounds that can modulate the activity of this enzyme. These activators can either enhance or inhibit the catalytic activity of α enolase, depending on their specific chemical properties and binding sites. The modulation of α enolase activity can impact glycolysis and, by extension, the cellular energy balance. Furthermore, it can influence the plasminogen activation pathway, which plays a role in tissue remodeling and cell migration, making α enolase a target for interventions in various physiological and pathological contexts. Understanding the mechanisms and consequences of α enolase activation is vital for unraveling its multifunctional roles in cellular biology and may have implications in diverse fields, from cancer research to metabolic diseases, where dysregulation of glycolysis and cell migration are central features.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cobalt(II) chloride | 7646-79-9 | sc-252623 sc-252623A | 5 g 100 g | $64.00 $176.00 | 7 | |
Under hypoxic conditions or in the presence of HIF-1α stabilizers, ENO1 expression might be upregulated as part of the cellular response to low oxygen. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Can modulate glycolytic enzyme expression, potentially affecting ENO1. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
Stimulates immune cells and can activate various signaling pathways, potentially influencing ENO1 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Influences cell differentiation and might modulate ENO1 expression in certain contexts. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC and various signaling pathways, potentially influencing ENO1 expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates intracellular cAMP levels, which might influence ENO1 expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A glucocorticoid that can modulate various cellular responses, potentially influencing ENO1 expression. | ||||||